These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 19902080)

  • 1. Model for alternative splicing of insulin receptor in myotonic dystrophy type 1.
    Tonevitsky EA; Trushkin EV
    Bull Exp Biol Med; 2009 Jun; 147(6):772-6. PubMed ID: 19902080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin receptor splicing alteration in myotonic dystrophy type 2.
    Savkur RS; Philips AV; Cooper TA; Dalton JC; Moseley ML; Ranum LP; Day JW
    Am J Hum Genet; 2004 Jun; 74(6):1309-13. PubMed ID: 15114529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DM1 CTG expansions affect insulin receptor isoforms expression in various tissues of transgenic mice.
    Guiraud-Dogan C; Huguet A; Gomes-Pereira M; Brisson E; Bassez G; Junien C; Gourdon G
    Biochim Biophys Acta; 2007 Dec; 1772(11-12):1183-91. PubMed ID: 17950578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy.
    Savkur RS; Philips AV; Cooper TA
    Nat Genet; 2001 Sep; 29(1):40-7. PubMed ID: 11528389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resveratrol enhances splicing of insulin receptor exon 11 in myotonic dystrophy type 1 fibroblasts.
    Takarada T; Nishida A; Takeuchi A; Lee T; Takeshima Y; Matsuo M
    Brain Dev; 2015 Aug; 37(7):661-8. PubMed ID: 25476247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular mechanisms responsible for aberrant splicing of SERCA1 in myotonic dystrophy type 1.
    Hino S; Kondo S; Sekiya H; Saito A; Kanemoto S; Murakami T; Chihara K; Aoki Y; Nakamori M; Takahashi MP; Imaizumi K
    Hum Mol Genet; 2007 Dec; 16(23):2834-43. PubMed ID: 17728322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myotonic dystrophy: emerging mechanisms for DM1 and DM2.
    Cho DH; Tapscott SJ
    Biochim Biophys Acta; 2007 Feb; 1772(2):195-204. PubMed ID: 16876389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNA pathogenesis of the myotonic dystrophies.
    Day JW; Ranum LP
    Neuromuscul Disord; 2005 Jan; 15(1):5-16. PubMed ID: 15639115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrantly spliced alpha-dystrobrevin alters alpha-syntrophin binding in myotonic dystrophy type 1.
    Nakamori M; Kimura T; Kubota T; Matsumura T; Sumi H; Fujimura H; Takahashi MP; Sakoda S
    Neurology; 2008 Feb; 70(9):677-85. PubMed ID: 18299519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Staufen1 Regulates Multiple Alternative Splicing Events either Positively or Negatively in DM1 Indicating Its Role as a Disease Modifier.
    Bondy-Chorney E; Crawford Parks TE; Ravel-Chapuis A; Klinck R; Rocheleau L; Pelchat M; Chabot B; Jasmin BJ; Côté J
    PLoS Genet; 2016 Jan; 12(1):e1005827. PubMed ID: 26824521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered mRNA splicing of dystrophin in type 1 myotonic dystrophy.
    Nakamori M; Kimura T; Fujimura H; Takahashi MP; Sakoda S
    Muscle Nerve; 2007 Aug; 36(2):251-7. PubMed ID: 17487865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alternative splicing of PDLIM3/ALP, for α-actinin-associated LIM protein 3, is aberrant in persons with myotonic dystrophy.
    Ohsawa N; Koebis M; Suo S; Nishino I; Ishiura S
    Biochem Biophys Res Commun; 2011 May; 409(1):64-9. PubMed ID: 21549096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mass spectrometry analysis of complexes formed by myotonic dystrophy protein kinase (DMPK).
    Forner F; Furlan S; Salvatori S
    Biochim Biophys Acta; 2010 Jun; 1804(6):1334-41. PubMed ID: 20188867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenic RNA repeats: an expanding role in genetic disease.
    Ranum LP; Day JW
    Trends Genet; 2004 Oct; 20(10):506-12. PubMed ID: 15363905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain-specific change in alternative splicing of Tau exon 6 in myotonic dystrophy type 1.
    Leroy O; Wang J; Maurage CA; Parent M; Cooper T; Buée L; Sergeant N; Andreadis A; Caillet-Boudin ML
    Biochim Biophys Acta; 2006 Apr; 1762(4):460-7. PubMed ID: 16487687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Myotonic Dystrophy: Advances in Translational Research].
    Nakamori M; Takahashi MP
    Brain Nerve; 2017 Jan; 69(1):61-69. PubMed ID: 28126979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colocalization of muscleblind with RNA foci is separable from mis-regulation of alternative splicing in myotonic dystrophy.
    Ho TH; Savkur RS; Poulos MG; Mancini MA; Swanson MS; Cooper TA
    J Cell Sci; 2005 Jul; 118(Pt 13):2923-33. PubMed ID: 15961406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alternative splicing of myomesin 1 gene is aberrantly regulated in myotonic dystrophy type 1.
    Koebis M; Ohsawa N; Kino Y; Sasagawa N; Nishino I; Ishiura S
    Genes Cells; 2011 Sep; 16(9):961-72. PubMed ID: 21794030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of the [CCTG]n repeat expansion on ZNF9 expression in myotonic dystrophy type II (DM2).
    Botta A; Caldarola S; Vallo L; Bonifazi E; Fruci D; Gullotta F; Massa R; Novelli G; Loreni F
    Biochim Biophys Acta; 2006 Mar; 1762(3):329-34. PubMed ID: 16376058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Molecular pathways to myotonic dystrophy].
    Ishiura S
    Nihon Rinsho; 2005 Mar; 63(3):515-21. PubMed ID: 15773354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.